The COVID-19 pandemic has resulted in an incomparable disease burden worldwide. One
of the main contributors stems from the multisystem inflammatory syndrome associated with …

Our three year retrospective cohort study demonstrated that the vast majority of patients
tolerated the switch from adalimumab originator to adalimumab biosimilar, with a 19 …

In more severe cases, surface ulceration can occur. 2 Given the rarity of NL, treatment is
largely guided by case report data and randomised controlled trials are lacking. GLO …

Immunotherapy is emerging as a promising alternative treatment for a variety of solid tumors.
Its beneficial effects are mediated through hijacking the immune system to mount an anti …

Biological drugs have revolutionized the treatment of immune-mediated inflammatory
diseases. Clinical experience and evidence suggest that biosimilars can be used as safely …

Cutaneous squamous cell carcinoma (cSCC) is a keratinocyte tumour with excellent
prognosis following early-stage surgical treatment. Nevertheless, cSCC possesses an …

A 69-year-old woman presented with an 18-month history of recurrent bruising of the
eyelids. She was otherwise asymptomatic and systems review was unremarkable. On …

A 34-year-old multiparous woman with no dermatological history presented at 16 weeks of
gestation with a fourweek history of a severely pruritic rash initially affecting the inner thighs …

Background: Although Asian American and Pacific Islanders (AAPI) are at lower risk for
developing melanoma compared to non-Hispanic white (NHW) populations, AAPI have …

Since the Covid-19 pandemic began in January 2020, medical professionals worldwide
have had to alter their clinical practice. Many have limited their face-to-face consultations …